Summary of all participants’ results for MRD-positive samples (1-8)
Sample . | RUNX1::RUNX1T1 . | CBFB::MYH11 . | PML::RARA . | NPM1 . | ||||
---|---|---|---|---|---|---|---|---|
1 . | 2 . | 3 . | 4 . | 5 . | 6 . | 7 . | 8 . | |
n | 23 | 23 | 23∗ | 23∗ | 22 | 22 | 23 | 23 |
Detection rate (%) | 100 | 100 | 100 | 95.7 | 100 | 95.5 | 100 | 91.3 |
Median† | 151.0 | 0.29 | 35.8 | 0.026 | 2.1 | 0.019 | 55.2 | 0.010 |
Mean† | 179.0 | 0.34 | 39.8 | 0.033 | 2.5 | 0.026 | 64.8 | 0.011 |
SD† | 103.6 | 0.24 | 18.2 | 0.020 | 1.7 | 0.018 | 43.2 | 0.008 |
CV (%)† | 57.9 | 70.22 | 45.6 | 60.2 | 66.6 | 68.5 | 66.6 | 71.4 |
Minimum† | 31.0 | 0.05 | 2.4 | 0.01 | 0.7 | 0.005 | 0.25 | 0.003 |
Maximum† | 462.0 | 1.15 | 79.0 | 0.080 | 6.7 | 0.073 | 195.4 | 0.031 |
Sample . | RUNX1::RUNX1T1 . | CBFB::MYH11 . | PML::RARA . | NPM1 . | ||||
---|---|---|---|---|---|---|---|---|
1 . | 2 . | 3 . | 4 . | 5 . | 6 . | 7 . | 8 . | |
n | 23 | 23 | 23∗ | 23∗ | 22 | 22 | 23 | 23 |
Detection rate (%) | 100 | 100 | 100 | 95.7 | 100 | 95.5 | 100 | 91.3 |
Median† | 151.0 | 0.29 | 35.8 | 0.026 | 2.1 | 0.019 | 55.2 | 0.010 |
Mean† | 179.0 | 0.34 | 39.8 | 0.033 | 2.5 | 0.026 | 64.8 | 0.011 |
SD† | 103.6 | 0.24 | 18.2 | 0.020 | 1.7 | 0.018 | 43.2 | 0.008 |
CV (%)† | 57.9 | 70.22 | 45.6 | 60.2 | 66.6 | 68.5 | 66.6 | 71.4 |
Minimum† | 31.0 | 0.05 | 2.4 | 0.01 | 0.7 | 0.005 | 0.25 | 0.003 |
Maximum† | 462.0 | 1.15 | 79.0 | 0.080 | 6.7 | 0.073 | 195.4 | 0.031 |